Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1987 Jul;206(1):48–52. doi: 10.1097/00000658-198707000-00007

Emergency portacaval shunt for variceal hemorrhage. A prospective study.

J P Villeneuve, G Pomier-Layrargues, L Duguay, R Lapointe, S Tanguay, D Marleau, B Willems, P M Huet, C Infante-Rivard, P Lavoie
PMCID: PMC1492922  PMID: 3496860

Abstract

Emergency portacaval shunt for variceal bleeding is associated with a high operative mortality, particularly if used as a last resort. Because of this, a strong case has been made against emergency shunt. This report describes an experience with emergency portacaval shunt for the treatment of variceal bleeding when used systematically after hemodynamic stabilization and control of the bleeding episode with balloon tamponade, if necessary, in patients with mild or moderate liver disease. The population studied comprised 62 consecutive patients who rebled from varices while participating in a controlled trial of propranolol for the prevention of rebleeding. Of the 62 patients, nine died of massive hemorrhage and 53 survived the hemorrhage. Of the 53 survivors, 11 had severe liver disease and were not considered for shunt surgery. Of the remaining 42 patients with mild or moderate liver disease, 36 had emergency central portacaval shunt. The interval between endoscopic diagnosis of variceal bleeding and surgery averaged 19 +/- 3 hours (mean +/- SE). The operative mortality rate, defined as in-hospital mortality, was 19%. One- and 2-year survival rates were 78% and 71%, respectively. The incidence of postoperative hepatic encephalopathy was 36%; all patients responded favorably to protein restriction and lactulose. Thus, under specific conditions, emergency portacaval shunt results in an acceptable long-term survival rate. In patients with mild or moderate liver disease, emergency portacaval shunt should be considered when other forms of treatment for the prevention of variceal rebleeding have failed.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barsoum M. S., Bolous F. I., El-Rooby A. A., Rizk-Allah M. A., Ibrahim A. S. Tamponade and injection sclerotherapy in the management of bleeding oesophageal varices. Br J Surg. 1982 Feb;69(2):76–78. doi: 10.1002/bjs.1800690206. [DOI] [PubMed] [Google Scholar]
  2. Bernuau J., Rueff B. Treatment of acute variceal bleeding. Clin Gastroenterol. 1985 Jan;14(1):185–207. [PubMed] [Google Scholar]
  3. Cello J. P., Grendell J. H., Crass R. A., Trunkey D. D., Cobb E. E., Heilbron D. C. Endoscopic sclerotherapy versus portacaval shunt in patients with severe cirrhosis and variceal hemorrhage. N Engl J Med. 1984 Dec 20;311(25):1589–1594. doi: 10.1056/NEJM198412203112501. [DOI] [PubMed] [Google Scholar]
  4. Conn H. O. Ideal treatment of portal hypertension in 1985. Clin Gastroenterol. 1985 Jan;14(1):259–288. [PubMed] [Google Scholar]
  5. DiMagno E. P., Zinsmeister A. R., Larson D. E., Viggiano T. R., Clain J. E., Laughlin B. L., Hughes R. W., Jr Influence of hepatic reserve and cause of esophageal varices on survival and rebleeding before and after the introduction of sclerotherapy: a retrospective analysis. Mayo Clin Proc. 1985 Mar;60(3):149–157. doi: 10.1016/s0025-6196(12)60211-0. [DOI] [PubMed] [Google Scholar]
  6. Graham D. Y., Smith J. L. The course of patients after variceal hemorrhage. Gastroenterology. 1981 Apr;80(4):800–809. [PubMed] [Google Scholar]
  7. Jones P. F., Johnston S. J., McEwan A. B., Kyle J., Needham C. D. Further haemorrhage after admission to hospital for gastrointestinal haemorrhage. Br Med J. 1973 Sep 29;3(5882):660–664. doi: 10.1136/bmj.3.5882.660. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Langer B., Taylor B. R., Mackenzie D. R., Gilas T., Stone R. M., Blendis L. Further report of a prospective randomized trial comparing distal splenorenal shunt with end-to-side portacaval shunt. An analysis of encephalopathy, survival, and quality of life. Gastroenterology. 1985 Feb;88(2):424–429. doi: 10.1016/0016-5085(85)90502-5. [DOI] [PubMed] [Google Scholar]
  9. Orloff M. J., Bell R. H., Jr Long-term survival after emergency portacaval shunting for bleeding varices in patients with alcoholic cirrhosis. Am J Surg. 1986 Jan;151(1):176–183. doi: 10.1016/0002-9610(86)90029-2. [DOI] [PubMed] [Google Scholar]
  11. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Prandi D., Rueff B., Roche-Sicot J., Sicot C., Maillard J. N., Benhamou J. P., Fauvert R. Life-threatening hemorrhage of the digestive tract in cirrhotic patients. An assessment of the postoperative mortality after emergency portacaval shunt. Am J Surg. 1976 Feb;131(2):204–209. doi: 10.1016/0002-9610(76)90098-2. [DOI] [PubMed] [Google Scholar]
  13. Sarfeh I. J., Carter J. A., Welch H. F. Analysis of operative mortality after portal decompressive procedures in cirrhotic patients. Am J Surg. 1980 Aug;140(2):306–311. doi: 10.1016/0002-9610(80)90027-6. [DOI] [PubMed] [Google Scholar]
  14. Smith J. L., Graham D. Y. Variceal hemorrhage: a critical evaluation of survival analysis. Gastroenterology. 1982 May;82(5 Pt 1):968–973. [PubMed] [Google Scholar]
  15. Terblanche J., Bornman P. C., Kahn D., Jonker M. A., Campbell J. A., Wright J., Kirsch R. Failure of repeated injection sclerotherapy to improve long-term survival after oesophageal variceal bleeding. A five-year prospective controlled clinical trial. Lancet. 1983 Dec 10;2(8363):1328–1332. doi: 10.1016/s0140-6736(83)91090-5. [DOI] [PubMed] [Google Scholar]
  16. Trey C., Burns D. G., Saunders S. J. Treatment of hepatic coma by exchange blood transfusion. N Engl J Med. 1966 Mar 3;274(9):473–481. doi: 10.1056/NEJM196603032740901. [DOI] [PubMed] [Google Scholar]
  17. Villeneuve J. P., Pomier-Layrargues G., Infante-Rivard C., Willems B., Huet P. M., Marleau D., Viallet A. Propranolol for the prevention of recurrent variceal hemorrhage: a controlled trial. Hepatology. 1986 Nov-Dec;6(6):1239–1243. doi: 10.1002/hep.1840060602. [DOI] [PubMed] [Google Scholar]
  18. Warren W. D., Henderson J. M., Millikan W. J., Galambos J. T., Brooks W. S., Riepe S. P., Salam A. A., Kutner M. H. Distal splenorenal shunt versus endoscopic sclerotherapy for long-term management of variceal bleeding. Preliminary report of a prospective, randomized trial. Ann Surg. 1986 May;203(5):454–462. doi: 10.1097/00000658-198605000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Westaby D., Macdougall B. R., Williams R. Improved survival following injection sclerotherapy for esophageal varices: final analysis of a controlled trial. Hepatology. 1985 Sep-Oct;5(5):827–830. doi: 10.1002/hep.1840050520. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES